Fidelity Select Biotechnology Portfolio (FBIOX) - Health fund with $5.26 Billion in assets. The fund allocates 62.97% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is ABBVIE INC at 16.67% of total assets. This is followed by AMGEN INC (8.21%) and KRYSTAL BIOTECH INC (6.48%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| ABBVIE INC | 16.67% | - | - |
| AMGEN INC | 8.21% | - | - |
| KRYSTAL BIOTECH INC | 6.48% | - | - |
| Fidelity Securities Lending Cash Central Fund | 5.00% | - | - |
| REGENERON PHARMACEUTICALS INC | 3.02% | - | - |
| VERTEX PHARMACEUTICALS INC | 4.56% | - | - |
| ALNYLAM PHARMACEUTICALS INC | 6.92% | - | - |
| GILEAD SCIENCES INC | 8.05% | - | - |
| UCB SA | 2.09% | - | - |
| ZEALAND PHARMA A/S | 1.97% | - | - |
| ARGENX SE SPONSORED ADR | 2.78% | - | - |
| ASCENDIS PHARMA AS SPON ADR | 2.68% | - | - |
| INSMED INC | 3.24% | - | - |